BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10715539)

  • 1. Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate.
    Singh A; Purohit A; Hejaz HA; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2000 Feb; 160(1-2):61-6. PubMed ID: 10715539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells.
    MacCarthy-Morrogh L; Townsend PA; Purohit A; Hejaz HAM ; Potter BVL ; Reed MJ; Packham G
    Cancer Res; 2000 Oct; 60(19):5441-50. PubMed ID: 11034086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours.
    Purohit A; Hejaz HA; Walden L; MacCarthy-Morrogh L; Packham G; Potter BV; Reed MJ
    Int J Cancer; 2000 Feb; 85(4):584-9. PubMed ID: 10699934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
    Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat liver microsomal estrogen 2-hydroxylase by 2-methoxyestrogens.
    Brueggemeier RW; Singh U
    J Steroid Biochem; 1989 Oct; 33(4A):589-93. PubMed ID: 2811369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates.
    Leese MP; Leblond B; Newman SP; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):239-51. PubMed ID: 15862971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of immunogenic C-6 derivatives of 2-methoxyestrone and 2-methoxyestradiol-17 beta and characterization of the corresponding antisera.
    Berg D; Warnecke HH; Kuss E
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):737-44. PubMed ID: 6290363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures.
    Seeger H; Mueck AO; Lippert TH
    Life Sci; 1999; 65(13):PL167-70. PubMed ID: 10503964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.
    Purohit A; Singh A; Ghilchik MW; Reed MJ
    Biochem Biophys Res Commun; 1999 Jul; 261(1):214-7. PubMed ID: 10405348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells.
    Day JM; Newman SP; Comninos A; Solomon C; Purohit A; Leese MP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):317-25. PubMed ID: 12711018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
    Newman SP; Leese MP; Purohit A; James DR; Rennie CE; Potter BV; Reed MJ
    Int J Cancer; 2004 Apr; 109(4):533-40. PubMed ID: 14991574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.
    Santner SJ; Ohlsson-Wilhelm B; Santen RJ
    Int J Cancer; 1993 Apr; 54(1):119-24. PubMed ID: 8478138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.
    Nozawa T; Suzuki M; Takahashi K; Yabuuchi H; Maeda T; Tsuji A; Tamai I
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1032-7. PubMed ID: 15328376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
    Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
    Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microtubules in glucose uptake by C6 glioma cells.
    Singh SP; Gao Y; Singh LD; Kunapuli SP; Ravindra R
    Pharmacol Toxicol; 1998 Aug; 83(2):83-9. PubMed ID: 9783325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.
    Newman SP; Ireson CR; Tutill HJ; Day JM; Parsons MF; Leese MP; Potter BV; Reed MJ; Purohit A
    Cancer Res; 2006 Jan; 66(1):324-30. PubMed ID: 16397246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
    Pasqualini JR; Gelly C; Nguyen BL
    Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells.
    Nozawa T; Suzuki M; Yabuuchi H; Irokawa M; Tsuji A; Tamai I
    Pharm Res; 2005 Oct; 22(10):1634-41. PubMed ID: 16180120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation.
    Vandewalle B; Lefebvre J
    Mol Cell Endocrinol; 1989 Feb; 61(2):239-46. PubMed ID: 2537243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.